Ischemic tolerance is associated with VEGF-C and VEGFR-3 signaling in the mouse hippocampus

Neuroscience. 2015 Apr 2:290:90-102. doi: 10.1016/j.neuroscience.2015.01.025. Epub 2015 Jan 28.

Abstract

The functions of vascular endothelial growth factor C (VEGF-C) and the VEGF receptor 3 (VEGFR-3) in the nervous system are not well known. In this study, we examined the role of VEGF-C and VEGFR-3 in ischemic preconditioning (IPC)-induced tolerance in the mouse hippocampus. Adult male C57BL/6 mice were subjected to either severe ischemia (SI) induced by 40 min of bilateral common carotid artery occlusion (BCCAO) with or without IPC (5-min BCCAO) or IPC only. Cerebral blood flow was measured during ischemic periods using laser Doppler flowmetry. Neuronal damage was assessed histologically, and VEGF-C and VEGFR-3 expression levels were assessed through immunostaining. Fluoro-Jade B-labeled cells were abundant in the CA1 area 7 days after SI without IPC (sham+SI group), whereas cells were rarely labeled in mice subjected to IPC followed by SI (IPC+SI group). Similarly, the number of neuronal nuclei (NeuN)-positive cells in the CA1 area was significantly lower in the sham+SI group than in the IPC+SI group. Interestingly, we found that sublethal IPC treatment induced prominent VEGF-C expression in the CA1 pyramidal neurons and VEGFR-3 expression in the stratum radiatum and stratum lacunosum moleculare after 3 days of reperfusion that were sustained for 7 days. Moreover, VEGF-C immunoreactivity was also markedly increased, whereas VEGFR-3 expression was sustained in tolerance-acquired CA1 neurons after SI. Application of a VEGFR-3 inhibitor, SAR131675, abolished the IPC-induced neuroprotection in a dose-dependent manner in the mouse hippocampus. These results suggest that VEGF-C/VEGFR-3 signaling is associated with IPC-induced hippocampal tolerance to lethal ischemia.

Keywords: VEGF-C; VEGFR-3; cerebral ischemia; ischemic preconditioning; ischemic tolerance.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Brain Ischemia / metabolism*
  • Brain Ischemia / pathology
  • CA1 Region, Hippocampal / drug effects
  • CA1 Region, Hippocampal / metabolism*
  • CA1 Region, Hippocampal / pathology
  • Carotid Artery Diseases
  • Cell Count
  • Central Nervous System Agents / pharmacology
  • DNA-Binding Proteins
  • Disease Models, Animal
  • Dose-Response Relationship, Drug
  • Fluoresceins
  • Fluorescent Antibody Technique
  • Ischemic Preconditioning / methods*
  • Male
  • Mice, Inbred C57BL
  • Naphthyridines / pharmacology
  • Nerve Tissue Proteins / metabolism
  • Neurons / drug effects
  • Neurons / metabolism*
  • Neurons / pathology
  • Nuclear Proteins / metabolism
  • Vascular Endothelial Growth Factor C / metabolism*
  • Vascular Endothelial Growth Factor Receptor-3 / antagonists & inhibitors
  • Vascular Endothelial Growth Factor Receptor-3 / metabolism*

Substances

  • Central Nervous System Agents
  • DNA-Binding Proteins
  • Fluoresceins
  • Naphthyridines
  • Nerve Tissue Proteins
  • NeuN protein, mouse
  • Nuclear Proteins
  • SAR131675
  • Vascular Endothelial Growth Factor C
  • fluoro jade
  • vascular endothelial growth factor C, mouse
  • Vascular Endothelial Growth Factor Receptor-3